Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
Lars Wallentin(Uppsala University), Stefan James(Uppsala University), Robert F. Storey(University of Sheffield), Martin Armstrong(AstraZeneca (United Kingdom)), Bryan J. Barratt(AstraZeneca (United Kingdom)), Jay Horrow(AstraZeneca (United Kingdom)), Steen Husted(Aarhus University Hospital), Hugo A. Katus(Heidelberg University), Philippe Gabríel Steg(Inserm), Svati H. Shah(Clinical Research Institute), Richard C. Becker(Clinical Research Institute)
Cited by 798
Abstract
Related Papers
No related papers found
Powered by citation graph analysis